268 related articles for article (PubMed ID: 9590243)
1. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences.
Lee N; Goodlett DR; Ishitani A; Marquardt H; Geraghty DE
J Immunol; 1998 May; 160(10):4951-60. PubMed ID: 9590243
[TBL] [Abstract][Full Text] [Related]
2. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
3. Features of TAP-independent MHC class I ligands revealed by quantitative mass spectrometry.
Weinzierl AO; Rudolf D; Hillen N; Tenzer S; van Endert P; Schild H; Rammensee HG; Stevanović S
Eur J Immunol; 2008 Jun; 38(6):1503-10. PubMed ID: 18446792
[TBL] [Abstract][Full Text] [Related]
4. TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide.
Braud VM; Allan DS; Wilson D; McMichael AJ
Curr Biol; 1998 Jan; 8(1):1-10. PubMed ID: 9427624
[TBL] [Abstract][Full Text] [Related]
5. HLA-E surface expression is independent of the availability of HLA class I signal sequence-derived peptides in human tumor cell lines.
Palmisano GL; Contardi E; Morabito A; Gargaglione V; Ferrara GB; Pistillo MP
Hum Immunol; 2005 Jan; 66(1):1-12. PubMed ID: 15620456
[TBL] [Abstract][Full Text] [Related]
6. The effect of the proteasome inhibitor lactacystin on the presentation of transporter associated with antigen processing (TAP)-dependent and TAP-independent peptide epitopes by class I molecules.
Bai A; Forman J
J Immunol; 1997 Sep; 159(5):2139-46. PubMed ID: 9278300
[TBL] [Abstract][Full Text] [Related]
7. TAP (transporter associated with antigen processing)-independent presentation of endogenously synthesized peptides is enhanced by endoplasmic reticulum insertion sequences located at the amino- but not carboxyl-terminus of the peptide.
Bacik I; Cox JH; Anderson R; Yewdell JW; Bennink JR
J Immunol; 1994 Jan; 152(2):381-7. PubMed ID: 8283027
[TBL] [Abstract][Full Text] [Related]
8. Tap-1 and Tap-2 gene therapy selectively restores conformationally dependent HLA Class I expression in type I diabetic cells.
Wang F; Li X; Annis B; Faustman DL
Hum Gene Ther; 1995 Aug; 6(8):1005-17. PubMed ID: 7578413
[TBL] [Abstract][Full Text] [Related]
9. Peptide-dependent expression of HLA-B7 on antigen processing-deficient T2 cells.
Smith KD; Lutz CT
J Immunol; 1996 May; 156(10):3755-64. PubMed ID: 8621911
[TBL] [Abstract][Full Text] [Related]
10. Alternative peptide repertoire of HLA-E reveals a binding motif that is strikingly similar to HLA-A2.
Lampen MH; Hassan C; Sluijter M; Geluk A; Dijkman K; Tjon JM; de Ru AH; van der Burg SH; van Veelen PA; van Hall T
Mol Immunol; 2013 Jan; 53(1-2):126-31. PubMed ID: 22898188
[TBL] [Abstract][Full Text] [Related]
11. Differences in the expression of human class I MHC alleles and their associated peptides in the presence of proteasome inhibitors.
Luckey CJ; Marto JA; Partridge M; Hall E; White FM; Lippolis JD; Shabanowitz J; Hunt DF; Engelhard VH
J Immunol; 2001 Aug; 167(3):1212-21. PubMed ID: 11466336
[TBL] [Abstract][Full Text] [Related]
12. HLA non-A,B,C class I genes: their structure and expression.
Heinrichs H; Orr HT
Immunol Res; 1990; 9(4):265-74. PubMed ID: 2089074
[TBL] [Abstract][Full Text] [Related]
13. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.
Romagnani C; Pietra G; Falco M; Mazzarino P; Moretta L; Mingari MC
Hum Immunol; 2004 May; 65(5):437-45. PubMed ID: 15172443
[TBL] [Abstract][Full Text] [Related]
14. The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association.
Lee N; Malacko AR; Ishitani A; Chen MC; Bajorath J; Marquardt H; Geraghty DE
Immunity; 1995 Nov; 3(5):591-600. PubMed ID: 7584149
[TBL] [Abstract][Full Text] [Related]
15. Antigen processing and presentation by human trophoblast-derived cell lines.
Gobin SJ; Wilson L; Keijsers V; Van den Elsen PJ
J Immunol; 1997 Apr; 158(8):3587-92. PubMed ID: 9103419
[TBL] [Abstract][Full Text] [Related]
16. Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences.
Neisig A; Roelse J; Sijts AJ; Ossendorp F; Feltkamp MC; Kast WM; Melief CJ; Neefjes JJ
J Immunol; 1995 Feb; 154(3):1273-9. PubMed ID: 7822796
[TBL] [Abstract][Full Text] [Related]
17. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
[TBL] [Abstract][Full Text] [Related]
18. Allele-specific differences in the interaction of MHC class I molecules with transporters associated with antigen processing.
Neisig A; Wubbolts R; Zang X; Melief C; Neefjes J
J Immunol; 1996 May; 156(9):3196-206. PubMed ID: 8617941
[TBL] [Abstract][Full Text] [Related]
19. The diversity of the HLA-E-restricted peptide repertoire explains the immunological impact of the Arg107Gly mismatch.
Celik AA; Kraemer T; Huyton T; Blasczyk R; Bade-Döding C
Immunogenetics; 2016 Jan; 68(1):29-41. PubMed ID: 26552660
[TBL] [Abstract][Full Text] [Related]
20. Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome.
Meissner M; Reichert TE; Kunkel M; Gooding W; Whiteside TL; Ferrone S; Seliger B
Clin Cancer Res; 2005 Apr; 11(7):2552-60. PubMed ID: 15814633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
